RLAY - Relay Therapeutics EPS misses by $0.01 beats on revenue November, 10 2021 04:52 PM Relay Therapeutics Inc. Relay Therapeutics (NASDAQ:RLAY): Q3 GAAP EPS of -$0.66 misses by $0.01. Revenue of $0.66M beats by $0.51M. Press Release For further details see: Relay Therapeutics EPS misses by $0.01, beats on revenue